{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n IMPA2 encodes myo‐inositol monophosphatase 2, a pivotal enzyme within the phosphatidylinositol signaling pathway that catalyzes the dephosphorylation of myo‐inositol monophosphate to liberate free inositol. Although it shares considerable homology with IMPA1, biochemical investigations reveal that IMPA2 exhibits distinct catalytic properties—including lower intrinsic activity, altered magnesium and pH requirements, and a slightly modified active‐site architecture—that may indicate a unique substrate specificity or regulatory mechanism."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Genetic and molecular studies have implicated IMPA2 in neuropsychiatric conditions. Variants and promoter polymorphisms in this gene have been associated with bipolar disorder, schizophrenia, and febrile seizures—findings that support a role for altered IMPA2 expression in modulating inositol availability and, by extension, the therapeutic mechanisms of lithium, which is known to inhibit IMPase activity. In particular, several association studies suggest that risk‐conferring alleles may elevate transcriptional activity of IMPA2 in the brain, thereby contributing to disease susceptibility and influencing treatment response."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "7"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond its role in the nervous system, IMPA2 deregulation has emerged in oncologic contexts. In clear cell renal cell carcinoma and cervical cancer, for instance, altered IMPA2 expression—modulated in part by microRNAs—correlates with enhanced cellular migration, proliferation, and metastatic potential through downstream effects on pathways such as mTOR and MAPK. Similarly, IMPA2 is a component of a metabolic gene signature that distinguishes subtypes of colon cancer and correlates with patient prognosis, underscoring its potential as a diagnostic and prognostic biomarker."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "11"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings indicate that IMPA2 is a multifunctional enzyme whose regulated activity is central to maintaining inositol homeostasis. Its differential expression and genetic variability appear to influence not only cellular signaling relevant to mood stabilization and neurodevelopment but also key oncogenic processes. Further elucidation of its structure–function relationships and regulatory networks may advance our understanding of both psychiatric and oncologic pathobiology.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Tetsuo Ohnishi, Hisako Ohba, Kyung-Chang Seo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M604474200"}], "href": "https://doi.org/10.1074/jbc.M604474200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17068342"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17068342"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Seisuke Fujita, Tetsuo Ohnishi, Shujiro Okuda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In silico study on the substrate binding manner in human myo-inositol monophosphatase 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Model (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00894-010-0937-8"}], "href": "https://doi.org/10.1007/s00894-010-0937-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21213002"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21213002"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Ryoichi Arai, Kaori Ito, Tetsuo Ohnishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proteins (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/prot.21299"}], "href": "https://doi.org/10.1002/prot.21299"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17340635"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17340635"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "G Sjøholt, R P Ebstein, R T Lie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.mp.4001460"}], "href": "https://doi.org/10.1038/sj.mp.4001460"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14699425"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14699425"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "T Yoshikawa, M Kikuchi, K Saito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.mp.4000835"}], "href": "https://doi.org/10.1038/sj.mp.4000835"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11317223"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11317223"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Tetsuo Ohnishi, Kazuo Yamada, Hisako Ohba, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.npp.1301307"}], "href": "https://doi.org/10.1038/sj.npp.1301307"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17251911"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17251911"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "I S Yoon, P P Li, K P Siu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.mp.4000901"}], "href": "https://doi.org/10.1038/sj.mp.4000901"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11673796"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11673796"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yuh-Feng Lin, Jian-Liang Chou, Jeng-Shou Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EBioMedicine (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ebiom.2019.06.006"}], "href": "https://doi.org/10.1016/j.ebiom.2019.06.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31202813"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31202813"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Kan Zhang, Lei Liu, Min Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel function of IMPA2, plays a tumor-promoting role in cervical cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-2507-z"}], "href": "https://doi.org/10.1038/s41419-020-2507-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32409648"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32409648"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jun Ren, Juan Feng, Wei Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Exp Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10238-020-00652-1"}], "href": "https://doi.org/10.1007/s10238-020-00652-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32772211"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32772211"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Md Nazim Uddin, Xiaosheng Wang "}, {"type": "b", "children": [{"type": "t", "text": "Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12282-022-01332-6"}], "href": "https://doi.org/10.1007/s12282-022-01332-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35020130"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35020130"}]}]}]}